17. Multiple system atrophy Clinical trials / Disease details
Clinical trials : 118 / Drugs : 163 - (DrugBank : 49) / Drug target genes : 61 - Drug target pathways : 112
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04782830 (ClinicalTrials.gov) | February 5, 2021 | 1/3/2021 | Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms | Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms | Orthostatic; Hypotension, Neurogenic;Autonomic Failure;Pure Autonomic Failure;Multiple System Atrophy; Hypotension, Parkinsonism | Device: Accelerometer;Drug: placebo pill;Drug: Midodrine or atomoxetine pill | Vanderbilt University Medical Center | NULL | Recruiting | 40 Years | 80 Years | All | 29 | N/A | United States |